Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Sep-Oct;34(5):446–452. doi: 10.2500/aap.2013.34.3694

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2013, OceanSide Publications, Inc., U.S.A.

PMC Copyright notice

Figure 2. — Response patterns of omalizumab to individual autoimmune markers. The number of patients on y-axis with complete (black bar), partial (gray bar), or no (white bar) response are shown for subgroups separated based on (A) antinuclear antibody (ANA), (B) antithyroglobulin (ATG), (C) antithyroperoxidase (ATPO), and (D) chronic urticaria (CU) index. Positive (+) and negative (−) for ANA, ATPO, ATG, and CU index were based on standards from the respective testing laboratory. The p values for statistical comparison of response patterns are shown in each panel.